← Back to all trials
Enrolling By Invitation
NCT05606900
Eye Movements Desensitization and Reprocessing Intervention in Preventing Craving in Alcohol Use Disorder
Conditions: Alcohol Use Disorder, Alcohol Craving
Sex: All
Ages: 18 Years – 65 Years
Phase: NA
Enrollment: 40
Sponsor: Ege University
Location: Turkey
Summary
This study is conducted to examine the effect of a psychotherapy model that is expected to affect alcohol cravings in adults aged 18-65 years who are being treated for alcohol use disorder at a clinic.
The psychotherapy intervention is expected to affect other variables such as clinical symptom level, self-efficacy level, and functionality level.
This protocol is called addiction-focused eye movement desensitization and reprocessing (addiction-focused EMDR).
Patients found suitable for the study will be divided into experimental and control groups.
The intervention will be applied to the experimental group and not to the control group.
At the end of the intervention, the effect of the intervention primarily on the level of craving will be compared with that of the control group.
The intervention is expected to reduce the level of craving.
The intervention is expected to have an impact on the other variables mentioned as well.
Eligibility Criteria
Inclusion Criteria:Having the criteria for the diagnosis of alcohol use disorder according to DSM-5,Continuing or completing the standard treatment applied in the addiction clinic,Being between the ages of 18-65.Exclusion Criteria:As a result of the clinical interview, meeting the criteria for any of the disorders included in the classifications of:"Bipolar and related disorders" with psychotic features,"Depression disorders" with psychotic features,"Dissociative disorders" such as depersonalization, derealization, dissociative identity disorder,"Schizophrenia spectrum and disorders leading to psychosis" such as schizophrenia, schizotypal personality disorder, schizoaffective disorder,Receiving any psychological or medical treatment other than the standard alcohol use disorder treatment administered in the Addiction Polyclinic,Having at least one of cardiovascular diseases, vertigo, epilepsy or eye diseases.
Source: ClinicalTrials.gov (NCT05606900). StuddyBuddy aggregates publicly available trial information.